The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Interim PSMA PET/CT for response evaluation during LuPSMA treatment in mCRPC (INTERIM PET): An explorative, multicenter study.
 
Andrei Gafita
No Relationships to Disclose
 
Isabel Rauscher
No Relationships to Disclose
 
Manuel Weber
No Relationships to Disclose
 
Boris A. Hadaschik
Consulting or Advisory Role - ABX Advanced biochemical compounds; Amgen; Astellas Pharma; Bayer; Janssen; Lightpoint medical; Merck KGaA; MSD
Research Funding - Janssen
Patents, Royalties, Other Intellectual Property - Uromed
Travel, Accommodations, Expenses - AstraZeneca; BMS; Janssen
 
Hui Wang
No Relationships to Disclose
 
Wesley R Armstrong
No Relationships to Disclose
 
Robert Tauber
No Relationships to Disclose
 
Johannes Czernin
Leadership - SOFIE; Trethera
Stock and Other Ownership Interests - SOFIE; Trethera
Consulting or Advisory Role - Actinium Pharmaceuticals; Endocyte; POINT Biopharma
 
Matthew Rettig
Consulting or Advisory Role - Ambrx; Amgen; Clovis Oncology; Johnson & Johnson
Speakers' Bureau - Bayer; Johnson & Johnson
Research Funding - Johnson & Johnson (Inst); Medivation/Astellas (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - I am a co-inventor on a patent for novel inhibitors of the N-terminal domain of the AR. There are NO commercial partnerships as of yet.
Travel, Accommodations, Expenses - Johnson & Johnson
 
Ken Herrmann
Leadership - SOFIE
Stock and Other Ownership Interests - SOFIE
Consulting or Advisory Role - Advanced Accelerator Applications; Amgen; Bain Capital; Bayer; BTG; GE Healthcare; IPSEN; ITG (Inst); Novartis; ROTOP Pharmaka (Inst); Siemens Healthineers
 
Jeremie Calais
Honoraria - Advanced Accelerator Applications; Progenics; Radiomedix
Consulting or Advisory Role - Blue Earth Diagnostics; Curium Pharma; GE Healthcare; Janssen; POINT Biopharma; Progenics; Telix Pharmaceuticals
Speakers' Bureau - IBA RadioPharma Solutions; Telix Pharmaceuticals
Research Funding - Progenics
 
Wolfgang A Weber
Consulting or Advisory Role - Blue Earth Diagnostics (Inst); ITG (Inst); Pentixapharm (Inst)
Research Funding - Blue Earth Diagnostics (Inst); ITG (Inst)
Patents, Royalties, Other Intellectual Property - Patent for PARP imaging agent
Travel, Accommodations, Expenses - Blue Earth Diagnostics; Pentixapharm
 
Matthias R. Benz
No Relationships to Disclose
 
Wolfgang Peter Fendler
Honoraria - Bayer; RadioMedix
Consulting or Advisory Role - BTG; Endocyte
 
Matthias Eiber
Consulting or Advisory Role - ABX Advanced biochemical compounds; Blue Earth Diagnostics
Research Funding - ABX Advanced biochemical compounds; Blue Earth Diagnostics; Siemens
Patents, Royalties, Other Intellectual Property - patent application for rhPSMA
Travel, Accommodations, Expenses - Bayer Schering Pharma